Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinical Trial Enrollment

- PMLiVE

Imbruvica gets FDA OK for rare lymphoma

Cancer drug available in US to treat Waldenström's macroglobulinaemia          

Biogen Idec building

Biogen Idec plans phase III Alzheimer’s trial before year-end

And MS drugs drive 2014 sales          

- PMLiVE

The FDA will not regulate your Apple Watches and Fitbits

US regulator clarifies its health wearables stance in draft guidance

Algeta execs join Targovax

Anna-Kirsti Aksnes and Tina Madsen join the firm

- PMLiVE

Biogen Idec enlists son of NFL star for MS campaign

Tyler Campbell’s own career was cut short by neurological disease

- PMLiVE

NICE backs first ‘ultra-orphan’ drug Soliris

Final guidance backs Alexion’s treatment for very rare blood clot condition

- PMLiVE

Global pledge to immunise 300 million children

Commitment made at GAVI Pledging Conference follows criticism of high vaccine prices

- PMLiVE

Products over pipeline in Pfizer’s acquisition targets, hints CEO

Sale forecasts for 2015 are down by up to $5bn compared to last year

- PMLiVE

New deputy commissioner at US FDA

Robert Califf is a vice chancellor at Duke University

Novartis building

Novartis sees first benefits from efficiency drive

Made $1.6bn in savings in 2014

- PMLiVE

Charity calls for universal liver health screening in UK

British Liver Trust will screen MPs as part of Love Your Liver campaign

- PMLiVE

Novartis begins sale talks for Horsham, UK site

Enters negotiations with the University of Brighton

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links